Capital De Empréstimo Alterar Data
AbbVie USD 62.48B 2.05B 2026-06
Abbott USD 29.45B 152M 2026-09
ALKERMES USD 1.47B 5.38M 2026-09
Amgen USD 51.61B 250M 2026-09
AstraZeneca USD 28.8B 2.79B 2026-09
Baxter International USD 8.62B 6M 2026-06
Biogen USD 7.29B 1.7M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Coherus Biosciences USD 51.08M 496K 2025-12
Drreddys Laboratories INR 11.69B 510M 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
Glaxosmithkline GBP 28.79B 10.26B 2026-09
J&J USD 35.8B 1.55B 2026-09
Medtronic USD 25.62B 502M 2026-06
Merck USD 49.69B 1.39B 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 38.38B 893M 2026-09
Novartis USD 36.7B 748M 2026-09
Novo Nordisk DKK 121.79B 2.62B 2026-06
Perrigo USD 3.28B 600K 2026-09
Pfizer USD 60B 498M 2026-09
Phibro Animal Health USD 585.85M 11.83M 2026-09
Prestige Brands USD 2.08B 54.81M 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 16.28B 1.63B 2026-09
Sanofi EUR 14.65B 2.35B 2026-06
United Therapeutics USD 100M 100M 2024-06
Zoetis USD 8.3B 749M 2026-09